Siemens Healthineers AG (ETR:SHL)
43.23
-0.59 (-1.35%)
Nov 20, 2026, 2:56 PM CET
Siemens Healthineers AG Ratios and Metrics
Market cap in millions EUR. Fiscal year is October - September.
Millions EUR. Fiscal year is Oct - Sep.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 19, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
| 48,078 | 42,239 | 51,212 | 60,096 | 53,731 | 49,516 | |
Market Cap Growth | 4.03% | -17.52% | -14.78% | 11.85% | 8.51% | -21.47% |
Enterprise Value | 60,345 | 54,942 | 64,579 | 74,946 | 68,714 | 63,842 |
Last Close Price | 43.82 | 37.97 | 44.94 | 51.72 | 45.24 | 40.96 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 19, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
PE Ratio | 21.94 | 19.08 | 23.89 | 30.95 | 35.61 | 24.30 |
Forward PE | 18.97 | 16.81 | 18.87 | 23.34 | 21.37 | 19.30 |
PS Ratio | 2.05 | 1.79 | 2.19 | 2.69 | 2.48 | 2.28 |
PB Ratio | 2.44 | 2.12 | 2.83 | 3.29 | 2.96 | 2.49 |
P/FCF Ratio | 19.78 | 17.28 | 18.87 | 28.21 | 41.94 | 29.97 |
P/OCF Ratio | 14.71 | 12.85 | 14.50 | 21.27 | 25.36 | 19.77 |
PEG Ratio | 2.31 | 2.21 | 1.77 | 1.94 | 1.87 | 2.11 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 19, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
EV/Sales Ratio | 2.57 | 2.33 | 2.76 | 3.35 | 3.17 | 2.94 |
EV/EBITDA Ratio | 13.83 | 12.54 | 15.85 | 20.06 | 21.28 | 16.20 |
EV/EBIT Ratio | 18.97 | 17.20 | 20.41 | 26.68 | 32.22 | 21.83 |
EV/FCF Ratio | 24.79 | 22.47 | 23.80 | 35.19 | 53.64 | 38.65 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 19, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Debt / Equity Ratio | 0.74 | 0.74 | 0.82 | 0.89 | 0.92 | 0.84 |
Debt / EBITDA Ratio | 3.36 | 3.36 | 3.45 | 4.11 | 4.83 | 4.02 |
Debt / FCF Ratio | 6.03 | 6.03 | 5.45 | 7.61 | 13.00 | 10.08 |
Net Debt / Equity Ratio | 0.61 | 0.61 | 0.70 | 0.74 | 0.79 | 0.77 |
Net Debt / EBITDA Ratio | 2.79 | 2.79 | 3.10 | 3.62 | 4.46 | 3.86 |
Net Debt / FCF Ratio | 4.99 | 4.99 | 4.65 | 6.35 | 11.25 | 9.21 |
Asset Turnover | 0.52 | 0.52 | 0.52 | 0.48 | 0.45 | 0.48 |
Inventory Turnover | 3.35 | 3.35 | 3.45 | 3.28 | 3.37 | 3.78 |
Quick Ratio | 0.75 | 0.75 | 0.75 | 0.85 | 0.68 | 0.71 |
Current Ratio | 1.18 | 1.18 | 1.12 | 1.25 | 1.05 | 1.11 |
Return on Equity (ROE) | 11.80% | 11.80% | 11.93% | 10.77% | 8.03% | 11.45% |
Return on Assets (ROA) | 4.38% | 4.38% | 4.37% | 3.79% | 2.79% | 4.02% |
Return on Invested Capital (ROIC) | 7.76% | 7.89% | 7.69% | 6.78% | 4.99% | 6.69% |
Return on Capital Employed (ROCE) | 9.50% | 9.50% | 10.00% | 8.10% | 6.40% | 7.90% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Nov '26 Nov 19, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Earnings Yield | 4.56% | 5.24% | 4.19% | 3.23% | 2.81% | 4.12% |
FCF Yield | 5.06% | 5.79% | 5.30% | 3.54% | 2.38% | 3.34% |
Dividend Yield | 2.31% | 2.63% | 2.18% | 1.77% | 1.97% | 2.15% |
Payout Ratio | 50.50% | 50.50% | 49.72% | 54.74% | 70.64% | 46.86% |
Buyback Yield / Dilution | 0.08% | 0.08% | -0.11% | 0.01% | 0.37% | -2.19% |
Total Shareholder Return | 2.38% | 2.71% | 2.07% | 1.78% | 2.34% | -0.04% |